• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖基蛋白治疗药物和抗原递送系统。

Chitosan-based delivery systems for protein therapeutics and antigens.

机构信息

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands.

出版信息

Adv Drug Deliv Rev. 2010 Jan 31;62(1):59-82. doi: 10.1016/j.addr.2009.11.009. Epub 2009 Nov 16.

DOI:10.1016/j.addr.2009.11.009
PMID:19925837
Abstract

Therapeutic peptides/proteins and protein-based antigens are chemically and structurally labile compounds, which are almost exclusively administered by parenteral injections. Recently, non-invasive mucosal routes have attracted interest for administration of these biotherapeutics. Chitosan-based delivery systems enhance the absorption and/or cellular uptake of peptides/proteins across mucosal sites and have immunoadjuvant properties. Chitosan is a mucoadhesive polysaccharide capable of opening the tight junctions between epithelial cells and it has functional groups for chemical modifications, which has resulted in a large variety of chitosan derivatives with tunable properties for the aimed applications. This review provides an overview of chitosan-based polymers for preparation of both therapeutic peptides/protein and antigen formulations. The physicochemical properties of these carrier systems as well as their applications in protein and antigen delivery through parenteral and mucosal (particularly nasal and pulmonary) administrations are summarized and discussed.

摘要

治疗性肽/蛋白质和基于蛋白质的抗原是化学和结构不稳定的化合物,几乎专门通过肠胃外注射给药。最近,非侵入性黏膜途径引起了人们对这些生物治疗药物给药的兴趣。基于壳聚糖的递药系统增强了肽/蛋白质在黏膜部位的吸收和/或细胞摄取,并且具有免疫佐剂特性。壳聚糖是一种具有黏膜黏附性的多糖,能够打开上皮细胞之间的紧密连接,并且具有用于化学修饰的功能基团,这导致了具有可调节特性的大量壳聚糖衍生物,可用于预期的应用。本文综述了用于制备治疗性肽/蛋白质和抗原制剂的壳聚糖基聚合物。总结和讨论了这些载体系统的物理化学性质及其在通过肠胃外和黏膜(特别是鼻内和肺部)途径给药的蛋白质和抗原传递中的应用。

相似文献

1
Chitosan-based delivery systems for protein therapeutics and antigens.壳聚糖基蛋白治疗药物和抗原递送系统。
Adv Drug Deliv Rev. 2010 Jan 31;62(1):59-82. doi: 10.1016/j.addr.2009.11.009. Epub 2009 Nov 16.
2
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.用于蛋白质药物肠道递送的聚离子水胶体:海藻酸盐和壳聚糖——综述
J Control Release. 2006 Aug 10;114(1):1-14. doi: 10.1016/j.jconrel.2006.04.017. Epub 2006 May 22.
3
Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.壳聚糖衍生物氯化三甲基壳聚糖(TMC)作为聚合物吸收增强剂的潜在前景:合成、表征及应用
J Pharm Pharmacol. 2008 Sep;60(9):1111-9. doi: 10.1211/jpp.60.9.0001.
4
Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.基于壳聚糖/透明质酸盐聚电解质复合物的新型粘膜粘附性鼻腔插入剂用于肽和蛋白质递送。
J Pharm Pharmacol. 2009 Feb;61(2):151-7. doi: 10.1211/jpp/61.02.0003.
5
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.负载蛋白质的N-三甲基壳聚糖纳米粒作为鼻腔给药系统的制备与表征
J Control Release. 2006 Mar 10;111(1-2):107-16. doi: 10.1016/j.jconrel.2005.11.014. Epub 2005 Dec 27.
6
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.用于非侵入性疫苗递送的单-N-羧甲基壳聚糖(MCC)和N-三甲基壳聚糖(TMC)纳米颗粒。
Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.
7
Chitosan-based hydrogels for controlled, localized drug delivery.壳聚糖基水凝胶用于控制和局部药物传递。
Adv Drug Deliv Rev. 2010 Jan 31;62(1):83-99. doi: 10.1016/j.addr.2009.07.019. Epub 2009 Sep 30.
8
Targeted delivery of low molecular drugs using chitosan and its derivatives.壳聚糖及其衍生物靶向递送低分子药物。
Adv Drug Deliv Rev. 2010 Jan 31;62(1):28-41. doi: 10.1016/j.addr.2009.10.003. Epub 2009 Oct 27.
9
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.用于鼻腔和肺部抗原及DNA递送的可生物降解的粘膜粘附微粒。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):411-30. doi: 10.1016/j.addr.2004.09.004.
10
The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.壳聚糖纳米粒在鼻腔给药中的应用。
Mar Drugs. 2020 Nov 29;18(12):605. doi: 10.3390/md18120605.

引用本文的文献

1
Chitosan-based formulations for therapeutic applications. A recent overview.用于治疗应用的基于壳聚糖的制剂。近期综述。
J Biomed Sci. 2025 Jul 8;32(1):62. doi: 10.1186/s12929-025-01161-7.
2
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.壳聚糖纳米颗粒:制备方法、关键特性、药物递送系统及治疗效果的进展
AAPS PharmSciTech. 2025 Apr 17;26(5):108. doi: 10.1208/s12249-025-03100-z.
3
Chitosan as a Plurivalent Biopolymer in Nanodelivery Systems.壳聚糖作为纳米递送系统中的多价生物聚合物
Polymers (Basel). 2025 Feb 20;17(5):558. doi: 10.3390/polym17050558.
4
Last Fifteen Years of Nanotechnology Application with Our Contribute.在我们的贡献下纳米技术应用的过去十五年。
Nanomaterials (Basel). 2025 Feb 10;15(4):265. doi: 10.3390/nano15040265.
5
Will the Real Immunogens Please Stand Up: Exploiting the Immunogenic Potential of Cryptococcal Cell Antigens in Fungal Vaccine Development.真正的免疫原请站出来:在真菌疫苗开发中利用隐球菌细胞抗原的免疫原性潜力。
J Fungi (Basel). 2024 Dec 4;10(12):840. doi: 10.3390/jof10120840.
6
Non-Ionic Surfactant Vesicles (Niosomes): Structure, Functions, Classification and its Advances in Enhanced Drug Delivery.非离子表面活性剂囊泡(Niosomes):结构、功能、分类及其在增强药物递送方面的进展
Recent Adv Drug Deliv Formul. 2024 Dec 9. doi: 10.2174/0126673878322982241126103404.
7
Progress and prospect of polysaccharides as adjuvants in vaccine development.多糖作为疫苗佐剂在疫苗开发中的进展与前景
Virulence. 2024 Dec;15(1):2435373. doi: 10.1080/21505594.2024.2435373. Epub 2024 Dec 5.
8
Natural biopolymer-based hydrogels: an advanced material for diabetic wound healing.基于天然生物聚合物的水凝胶:用于糖尿病伤口愈合的先进材料。
Diabetol Int. 2024 Jun 26;15(4):719-731. doi: 10.1007/s13340-024-00737-2. eCollection 2024 Oct.
9
PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice.PLGA-壳聚糖包载 IL-10 纳米颗粒调控小鼠沙眼衣原体感染炎症反应
Int J Nanomedicine. 2024 Feb 8;19:1287-1301. doi: 10.2147/IJN.S432970. eCollection 2024.
10
TPGS-modified Chitosan Nanoparticles of EGFR Inhibitor: Physicochemical and Evaluation against HepG2 Cell Lines.表皮生长因子受体抑制剂的TPGS修饰壳聚糖纳米颗粒:理化性质及对肝癌细胞系HepG2的评价
Curr Drug Deliv. 2025;22(4):465-478. doi: 10.2174/0115672018268315231206045504.